InvestorsHub Logo
Followers 0
Posts 438
Boards Moderated 0
Alias Born 09/22/2010

Re: BonelessCat post# 40502

Sunday, 10/24/2010 2:17:28 AM

Sunday, October 24, 2010 2:17:28 AM

Post# of 146301
Most preclinical assets have no value due to their early and risky nature. The VC community and microcap healthcare world is full of hundreds of phase I/preclinical opportunities that can be acquired for nominal equity value.

Not this company. Do you really think it's special or a transitory value established by spurious means? I'm voting on the latter until I see a CFO, a Board of Directors, a Nasdaq listing, an IND, a major institutional shareholder. Heck, I'll take just one of those. Otherwise I can buy 10 companies for the price of one. Why would I bother with NNVC?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News